Novel Immunotherapy Spotlight – Immune Monitoring and Tumor Escape

Learn about the latest immunotherapy innovations including novel biomarkers, factors that impact duration of response, bioinformatic approaches to mass cytometry, the use of t-SNE and PCA, and the role of TNF in resistance to immunotherapy and tumor escape in a solid tumor model. Read more about Plenary Session 5.

Patrick Hanley, PhD
Children’s National Medical Center
United States
Session Chair

Cameron Turtle, MBBS, PhD
Fred Hutchinson Cancer Research Center
United States
Speaker

Jane Oliaro, BSc (Hons), PhD
Peter MacCallum Cancer Centre
United States
Speaker

Emily Blyth, B. Med (Hons), PhD
Westmead Hospital
Australia
Speaker

WELCOME TO ISCT 2019 MELBOURNE

 SPONSOR AND EXHIBIT 

Don’t miss the chance to make new contacts, connect with current clients, develop your cell therapy, regenerative medicine and gene therapy business.

Corporate Opportunities

 ABOUT US 

Established in 1992, ISCT is a global society of clinicians, researchers, regulators, technologists and industry partners with a shared vision to translate safe and effective cell & gene therapies to improve patients’ lives worldwide.

Learn More

VISA REQUIREMENTS

Everyone who is not a New Zealand or Norfolk Island resident will need a visa to enter Australia. Please apply for your visa ASAP to ensure it is received in time.

Learn More

Location
1 Convention Centre Pl
South Wharf VIC 3006 Australia

Learn
Sessions to improve every aspect of cell therapy

Exhibit
Showcase to a global market.

Delegates
Over 50+ countries represented